ISSN: 2376-0389

Journal of Multiple Sclerosis
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 
 

Editorial Board

Editor Image

Editor-in-Chief
Kalipada Pahan
Rush University Medical Center
USA

Editor Image

Vasiliki E. Kalodimou
IASO Maternity Hospital of Athens
Greece

Editor Image

Cristina Granziera
University of Lausanne
Switzerland

View More»

Recommended Conferences

View More»
 

Submit Manuscript

Journal Impact Factor 1.65*
Submit manuscript at https://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jmso@omicsonline.org
 

About the Journal

Multiple Sclerosis is an inflammatory disease that disrupts the insulating cover of the nervous system. Human body depends heavily on the central nervous system, through which strategic information is communicated from brain to various parts of the body. Any imbalance in this system would result in severe physical and mental disorders. The mysterious nature of the disease provides extensive scope for research in this area. It affects the brain, central nervous system and the spinal cord.

The Journal of Multiple Sclerosis (JMSO) is an Open Access, peer reviewed, academic journal that aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them available online without any restrictions or any other subscriptions to researchers worldwide.

The editorial office promises a peer review process for the submitted manuscripts for the quality of publishing. The journal is using Editorial Manager System for quality in review process.Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of JMSO or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Disseminated Sclerosis

Disseminated sclerosis, also known as encephalomyelitis disseminata or Multiple Sclerosis (MS) is an inflammatory disease in which the insulating covers of nerve cells are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a wide range of signs and symptoms, mental, including physical and sometimes psychiatric problems. MS has several forms, with new symptoms either in relapsing forms or progressive forms.

Related Journals of Disseminated sclerosis.

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, Multiple Sclerosis International,  International Journal of MS Care, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders

Neurodegenerative Diseases

Neurodegeneration is the main feature for the progressive loss of structure or function of neurons, including degeneration of neurons. Examples of neurodegenerative diseases include Alzheimer’s, Parkinson’s, and Huntington’s disease. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias).

Related Journals of Neurodegenerative Diseases

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal, Neurodegenerative Diseases, Journal of Neurodegenerative Diseases, American Journal of Neurodegenerative Disease, Neurodegenerative Diseases Journal, Neurodegenerative Disease Management, Molecular Neurodegeneration, Austin Journal of Multiple Sclerosis & Neuroimmunology

Neuroimmunological Disorders

Neuroimmunology is study of nervous system and immunology and its disorders is immune system related nervous system (central or peripheral) diseases. Different types of interactions are involved in both the nervous and immune systems but not limited to the physiological functioning of the systems that leads to disorders and the chemical, physical and environmental stressors.

Related Journals of Neuroimmunological Disorders

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Journal of Neuroimmunology, Clinical and Experimental Neuroimmunology, Neurosurgery, Journal of Neuroimmune Pharmacology, Multiple Sclerosis and Neuroimmunology

Encephalomyelitis Disseminate

Acute Disseminated Encephalomyelitis (ADEM) is an immune-mediated inflammatory demyelinating condition that affects the brain and spinal cord’s white matter. The symptoms of ADEM appear speedily, beginning with encephalitis-like symptoms such as headache, fever, fatigue, nausea and vomiting. ADEM typically damages white matter, leading to neurological symptoms such as visual loss in one or both eyes, weakness even to the point of paralysis, and difficulty in voluntary muscle movements.

Related Journals of Encephalomyelitis Disseminate

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Journal of Neuroimmunology, Journal of Experimental Medicine, European Journal of Immunology, Journal of Neuropathology and Experimental Neurology, Journal of The Neurological Sciences, Journal of Neuroscience Research, Acta Neuropathologica, Journal of Natural Medicines

Immune-Mediated Disease

An immune-mediated inflammatory disease (IMID) is any of a group of conditions or diseases that play an etiological role, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from a deregulations of the normal immune response. All immune-mediated diseases can cause end organ damage, and are associated with increased morbidity and/or mortality. Immune-mediated diseases such as autoimmune diseases, allergic diseases, and asthma are present challenges worldwide. Multiple sclerosis is considered to be an immune-mediated disease in which the body's immune system attacks the central nervous system (CNS)

Related Journals of Immune-Mediated Disease

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Infection and Immunity, Journal of Neuroimmunology, Autoimmunity Reviews, Nature Reviews Immunology, Journal of Autoimmunity, Clinical Immunology, Journal of Allergy and Clinical Immunology, Immunology and Cell Biology, Journal of Clinical Immunology, Genes and Immunity

Progressive Multifocal Leukoencephalopathy

Progressive multifocal leukoencephalopathy (PML) is a rare neurological disorder but serious demyelinating disease of the brain, often resulting in severe disability or death; it is caused by virus called as JC virus (JCV).it is mostly seen in adult population and is harmless except among those with lowered immune defenses. PML is most common in HIV-1 infection/ acquired immune deficiency syndrome (AIDS) individuals. It is diagnosed by brain biopsy, Magnetic resonance imaging (MRI) scan, JC virus in spinal fluid detection.

Related Journals of  Progressive Multifocal Leukoencephalopathy

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal, New England Journal of Medicine, Journal of Neuropathology and Experimental Neurology, Journal of The Neurological Sciences, Journal of Neurology

Demyelination

Multiple sclerosis is a inflammatory demyelinating illness of the central nervous system showed morphologically by irritation, demyelination, axonal misfortune and gliosis. The pathological feature highlight of the sclerotic MS plaque is demyelination. Both the myelin sheath and the oligodendrocyte itself are devastated inside lesions, following assault by cells of the invulnerable framework that re-demonstration with myelin-related epitopes, for example, myelin essential protein. Insusceptible assault includes both cell immunity, with T cells coordinated at myelin and oligodendrocytes and impelling phagocytosis by macrophages, Demyelinated plaques can likewise be seen in the cortical and subcortical grey matter.

Related Journals of Demyelination
Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal, Acta Neuropathologica, Journal of Neuroimmunology, Journal of The Neurological Sciences, Muscle & Nerve, Journal of Neuropathology and Experimental Neurology, Journal of Neurology Neurosurgery and Psychiatry, Annals of Neurology , Brain

Neuromyelitis Optica

Neuromyelitis Optica (NMO), also known as Devic's disease or Devic's syndrome. Neuromyelitis Optica (NMO) is a rare relapsing autoimmune disorder that causes inflammation in the optic nerve and spinal cord. Several factors differentiate it from MS: 1) the severity of attacks is more robust as compared to MS, 2) it does not often involve the brain, especially early in the disease, and 3) the pathophysiology differs from MS – whereas MS is thought to largely be a T-cell mediated disease, NMO is mediated by anti-aquaporin 4 antibodies. Treatment for this disease involves acute management with therapies.

Related Journals of Neuromyelitis Optica

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal,Neurophysiology Journal, Neurosciences Journal, Journal of The Neurological Sciences, Multiple Sclerosis, Archives of Neurology, Journal of Neurology, Neurology, Journal of Neurology Neurosurgery and Psychiatry, Journal of Neuroimmunology, Neurological Sciences, European Neurology, Brain, Natural Medicines

Myelin Repair

Nerves are protected in the body by a coating called myelin. When myelin is worn away or damaged, nerves don’t work as well. They can deteriorate, causing problems inside the brain and throughout the body. Damage to the myelin sheath around nerves is called demyelination. The term demyelination describes a loss of myelin with relative preservation of axons. This results from diseases that damage myelin sheaths or the cells that form them. These diseases should be distinguished from those in which there is a failure to form myelin normally (sometimes described as demyelination).

Related Journals of Myelin Repair

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Experimental Neurology, Brain, Journal of Neuroimmunology, Journal of The Neurological Sciences, Nature Neuroscience,  Neurochemical Research, Neuroscience Letters

Neurorehabilitation

In serious disability, such as caused by a severe spinal injury or brain damage, the patient and their families' abilities, life style, and projects, are suddenly shattered. In order to cope with this situation, the person and their family must establish a "new way of living", both with their changed body and as a changed individual within their wider community. Thus, neurorehabilitation works with the skills and attitudes of the disabled person and their family and friends. It promotes their skills to work at the highest level of independence possible for them. It also encourages them to rebuild self-esteem and a positive mood. Thus, they can adapt to the new situation and become empowered for successful and committed community reintegration.

Related Journals of Neurorehabilitation

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,NeuroRehabilitation, Neurorehabilitation and Neural Repair, Journals in the field of Neurorehabilitation, Current Opinion in Neurology,Current Opinion in Neurobiology

Essential Tremor

Essential tremor is a nervous system disorder (neurological disorder) that causes a rhythmic shaking. Essential tremor can affect almost any part of your body, but the trembling occurs most often in your hands — especially when you try to do simple tasks, such as drinking from a glass, tying shoelaces, writing or shaving. Essential tremor may also affect your head, voice, arms or legs. Many different factors or diseases can also cause tremors, including Parkinson's disease, multiple sclerosis, fatigue after exercise, extreme emotional distress, brain tumors, some prescription drugs, metabolic abnormalities, and alcohol or drug withdrawal.

Related Journals of Essential Tremor

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Movement Disorders, Parkinsonism & Related Disorders, Journal of Neurology Neurosurgery and Psychiatry, Stereotactic and Functional Neurosurgery, Journal of Neurology, Clinical Neurophysiology, Neurology, Neuroepidemiology, Annals of Neurology

Manic-Depressive illness

Bipolar disorders also known as Manic-Depressive illness is  a mental condition marked by alternating periods of elation and depression.This causes extreme mood swings that include emotional highs (mania) and emotional lows (depression). These are divide into Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder and Other types. It is caused by biological difference, neurotransmitters and inherited traits. Medications include mood stabilizers (valproic acid, carbazepine), antipsychotics (lurasidone, ziprasidone), antidepressants and anti-anxiety like benzodiazepines.

Related Journals of Manic-Depressive illness

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Bipolar Disorders, Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets, Current Drug Targets: CNS and Neurological Disorders

Motor Neuron Disease

It includes a group of neurological disorders that destroy motor neurons, the cells that control voluntary muscle activity. There are classified into 5 types: amyotrophic lateral sclerosis, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, pseudobulbar plasy. It is treated with drugs like general anesthetics, amalgesics, addiction, epilepsy, cholinergics and others.

Related Journals of Motor Neuron Disease

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets, Current Drug Targets: CNS and Neurological Disorders, Multiple Sclerosis, Epilepsy Research, The Lancet Neurology

Alcoholic Neuropathy

Alcoholic Neuropathy is caused primarily by chronic alcoholism. Nutritional problems linked to alcohol use can also cause nerve damage. Symptoms of alcoholic neuropathy, like those of many of the other axonal mixed polyneuropathies, manifest initially in the distal lower extremities. Sensory symptoms (eg, numbness, dysesthesias, paresthesias, allodynia, and loss of vibration and position sense) generally manifest prior to motor symptoms (eg, weakness). However, patients may present with both motor and sensory symptoms at initial presentation. The exact cause of alcoholic neuropathy is not known. It includes direct poisoning of the nerve by the alcohol or may be the effect of poor nutrition associated with alcoholism.

Related Journals of Alcoholic Neuropathy

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Journal of Neurology Neurosurgery and Psychiatry, Muscle & Nerve, Journal of The Neurological Sciences, Annals of Neurology, Acta Neurologica Scandinavica, Alcohol and Alcoholism, European Archives of Psychiatry and Clinical Neuroscience

Advance Treatment for Multiple Sclerosis

There are diverse options for the treatment for Multiple Sclerosis that has been shown decreases the occurrence of relapses and impediment disease progression. Treatments can be use an injection either subcutaneous or intramuscular whereas others are given intravenously or orally. Some examples of injections are as Beta interferon’s (subcutaneous or intramuscular), Glatiramer acetate (subcutaneous injection), Fingolimod (oral capsule), Teriflunomide (oral tablet), Natalizumab (intravenous medication).

Related Journals of Advance Treatment for Multiple Sclerosis

Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, Multiple Sclerosis International,  International Journal of MS Care, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders, Neurosurgery, and Psychiatry

Multiple sclerosis (MS) Medications

There is no cure for multiple sclerosis. Treatment typically focuses on speeding recovery from attacks, slowing the progression of the disease and managing symptoms. Relapsing-remitting MS has certain medications which can lower the relapse rate and also formation of new lesions in early disease course. But no therapies have shown benefit for slowing the progression of primary-progressive MS. Certain disease-modifying drugs have been shown to reduce exacerbations and slow the progression of MS. Of which (Interferon drugs and Copaxone) are considered to be very safe. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under research.

Related Multiple Sclerosis Medications

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Multiple Sclerosis, Multiple Sclerosis and Related Disorders, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders - Drug Targets, Current Drug Targets: CNS and Neurological Disorders

Multiple Sclerosis Diagnosis

Multiple Sclerosis (MS) is an inflammatory disease of nervous system where it disrupts the insulating cover of nerves in brain and spinal cord resulting disability of the parts of the nervous system to communicate. Any imbalance results physical, mental and sometimes psychological problems may also occur. The mysterious nature of this disease provides wide-ranging scope for research there are several neurological examinations performed in general to detect this syndrome. The clinical and neurological tests includes: Flow Cytometry, MRI, spinal tap, evoked potentials etc.

Related Journals of Multiple Sclerosis Diagnosis

Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, Multiple Sclerosis International,  International Journal of MS Care, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, American Journal of Neuroradiology, Multiple Sclerosis and Related Disorders Home

Multiple Sclerosis Physical Therapy

Multiple Sclerosis (MS) is a disorder characterized by a loss of the myelin tissue that surrounds the nerves. Common symptoms include such as weakness in the legs or arms, loss of balance and problems with bladder function and mobility. Physical therapy is a significant part of the treatment process during the different stages of MS which plays a significant role in the rehabilitation process and improves quality of life for patients. By this patient maintains a degree of functionality and is able to perform daily activities without too much difficulty.

Related Journals of Multiple Sclerosis Physical Therapy

Brain Disorders Journal, Neuroinfectious Diseases, Neurological Disorders Journal, NeurologyJournal, Neurophysiology Journal, Neurosciences Journal,Therapeutic Advances in Neurological Disorders,Journal of Head Trauma Rehabilitation,  International Journal of MS Care, Consortium of Multiple Sclerosis, International Journal of Clinical and Health Psychology,Journal of health psychology

Journal Highlights

 

Major Disease Statistics

 
*Unofficial 2015 Journal Impact Factor was established by dividing the number of articles published in 2013 and 2014 with the number of times they are cited in 2015 based on Google search and the Scholar Citation Index database. If 'X' is the total number of articles published in 2013 and 2014, and 'Y' is the number of times these articles were cited in indexed journals during 2015 then, impact factor = Y/X

Recently Published Articles

 
Analysis of 258 Different Lesions of the Central Nervous System for Real Time Histopathological Diagnosis Using Confocal Laser Endomicroscopy

Samira D, Mehreen J, Ann-Kristin A, Alhadi I, Maximilian L, Richard B, Juergen S and Patra C

 
 
 
Effectiveness of Time Domain and Spectral Domain Optical Coherence Tomograph to Evaluate Eyes with And Without Optic Neuritis in Multiple Sclerosi Patients

Iester M, Cordano C, Costa A, D’Alessandro E, Panizzi A, Bisio F,  Masala A, Landi L, Traverso CE, Ferreras A, Mancardi GL and Uccelli A

 
Demyelination in Peripheral Nerves: Much to Learn from Leprosy Neuropathy

Mietto BS, Andrade PR, Jardim MR, Antunes SL and Sarno EN

 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version